Ascentage Pharma, Takeda forge $1.3bn deal to advance leukemia treatment

Ascentage Pharma (6855 HK), a leading biopharmaceutical company, has announced a significant development in its partnership strategy by signing an option agreement with Takeda Pharmaceutical ... Read More